This year, 1974, will be remembered for many events, among them the resignation of a President under threat of impeachment, continuing inflation, and military activities that imperiled world peace. Worries in the House of Medicine included such things as HMOs, PSROs, and National Health Insurance. On the scientific side, perhaps 1974 will be remembered as the year of high blood pressure, because the medical profession fully recognized that many hypertensive persons are unaware of their affliction and must be sought out by every means possible and brought to treatment.
The reasons for that attitude derived principally from the facts that in recent decades effective chemotherapy for hypertension had been developed and that such treatment forestalled the appearance of serious complications. For example, the Veterans Administration Cooperative Study Group on Antihypertensive Agents, under the chairmanship of Edward D. Freis, MD, had demonstrated the value of treatment in male hypertensive patients whose